An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn MoreAbout mild for Patients
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreAbout mild for Healthcare Professionals
Today, Vertos Medical announces that it has raised $26 million in an oversubscribed Series C equity funding round. The financing was led by new investor Norwest Venture Partners (@norwestvp) with participation from existing investors including Pitango Venture Capital.
“We are thrilled to have Norwest join our investor group,” said Eric Wichems, President and CEO of Vertos Medical. “With their support, we are confident in our ability to accelerate our commercial expansion and achieve our goal of making the Mild Procedure accessible to every patient suffering from lumbar spinal stenosis (LSS) in the United States.”
View full press release at the 🔗 link in bio.
#VertosMedical #PressRelease #CompanyAnnouncement #FinancingRound #Investors
Dr. Lisa Kroopf (@ladypaindoc) recently presented the Mild Procedure for lumbar spinal stenosis (LSS) at the @wipm_society & @mededcombine Virtual Lab! This innovative event brought together leading experts to showcase the latest advancements in interventional pain management therapies. The procedures were introduced through a virtual reality platform to provide an immersive and engaging experience.
To watch Dr. Kroopf’s presentation about Mild and learn more about the event, please visit the 🔗 link in bio.
📸 @mededcombine
There are millions of patients currently suffering from chronic low back pain (CLBP) caused by lumbar spinal stenosis (#LSS), and many of them are still searching for a treatment that provides lasting relief.
Dr. @jassalmd from @ExcelPainandSpine helps educate patients about their LSS condition and minimally invasive treatment options, such as the Mild Procedure.
Visit KnowYourBackStory.com or the 🔗 link in bio to learn more about CLBP, how it may be affecting patients in your practice, and information to help your LSS patients find relief.
Learn more about the Mild Procedure at the 🔗 link in bio.
We’re excited to welcome some great new talent to #TeamVertos!
Welcome aboard to Kyle Rasche, District Sales Manager, Christa Jaramillo, Clinical Specialist, Mike Shea, District Sales Manager, Linda Stepien, Clinical Specialist, Jon Betts, R&D Engineer II, Derek So, Quality Assurance Manager, Jen Kim, Senior Accountant, and Jacob Dowdy, Staff Accountant.
Interested in joining our team? Click the 🔗 link in bio for employment opportunities.
Our patient brochure is available in English and Spanish! This informative resource can help your lumbar spinal stenosis (#LSS) patients learn more about their condition and how the Mild Procedure can help.
Utilize the patient brochure to demonstrate the anatomical effects of LSS, educate patients about the benefits of Mild, and help patients prepare for their treatment.
Contact a Vertos Medical representative for more information about practice materials and view the patient brochures at the 🔗 link in bio.
We are #hiring and excited about growing #TeamVertos with new career opportunities. Join us on our mission to help lumbar spinal stenosis (#LSS) patients get on the path to lasting relief.
View current openings available throughout the U.S. and apply online at the link 🔗 in bio.
Vertos Medical is an Equal Employment Opportunity employer.
Hear from Dr. Mark Coleman from National Spine & Pain Centers on why he considers the Mild Procedure a beneficial treatment for patients suffering from lumbar spinal stenosis (#LSS).
From the minimally invasive nature of the procedure to its lasting results, Mild has a safety profile equivalent to an epidural steroid injection, and is a treatment that addresses the root cause of LSS by debulking the enlarged ligament.*
Learn more about the Mild Procedure at KnowYourBackStory.com or the 🔗 link in bio.
*Clinical data at the 🔗 link in bio.
If your patients are presenting with chronic low back pain, numbness, or tingling when standing or walking, they may be suffering from lumbar spinal stenosis (#LSS).
Get more patients in your practice on the path to lasting relief with the Mild Procedure by having them take a short survey to help assess their symptoms and determine if Mild is right for them at the 🔗 link in bio.
The Vertos team is growing! We’re excited to welcome Hugh Neuharth, Vice President of Finance, Bryn DenHeyer, Director of Upstream Marketing, Tom Ditter, Director of Product Development, Amy Zebrowski, District Sales Manager, Mike Choi, Human Resources Manager, Devan Ricard, Human Resources Generalist, Jake Akers, Cloud Data Architect, and LaRee Barrow, Systems Analyst, to Vertos Medical.
Welcome to #TeamVertos!
Interested in joining our team? Click the 🔗 link in bio for employment opportunities.
Today we celebrate Dr. Brent Chafin from ECU Health Roanoke-Chowan Hospital Pain Management Center, a true champion of spinal stenosis treatment! By making the Mild Procedure his standard of care for lumbar spinal stenosis (LSS), he’s positively impacted the lives of thousands. From all of us here at Vertos, we`re honored to work with you and learn from your expertise - you`re a true trailblazer in the treatment and advancement of
LSS care. 💙
While millions of patients suffer from chronic low back pain (CLBP), many have never been told by a healthcare provider exactly what causes it.*
By educating patients on the signs and symptoms of lumbar spinal stenosis (#LSS) and their available treatment options, you can help get even more patients on the path to lasting relief.
Visit KnowYourBackStory.com to view groundbreaking survey data about CLBP, and to learn more about the Mild Procedure for LSS.
*”Mobility Matters” Harris Poll data at the 🔗 link in bio.
@anjumbux @buxpain
Advanced Practice Providers (APPs) are a critical part of treatment care to help lumbar spinal stenosis (#LSS) patients get on the path to lasting relief. We’re helping APPs by providing valuable resources and support they need to educate patients about Mild.
Click the 🔗 link in bio to access our growing library of case studies, educational webinars, and peer insights on the Mild Procedure.
Join our Mild network at mildAPP.com to stay connected to the latest APP info and opportunities.
Across the country, the Mild Procedure for lumbar spinal stenosis is making headlines! Read about patient success stories from the South Central Regional Medical Center (@scrmc) in Mississippi, and Novant Health (@NovantHealth) in North Carolina. As quoted from one article, “My pain level has decreased to a level 2, and I have regained my quality of life.”
View their stories and other recent articles at the 🔗 link in bio.
This #NationalDoctorsDay we’re proud to honor our devoted physicians from across the country who dedicate themselves to delivering meaningful patient care.
Thank you for your compassion and commitment to helping patients achieve a greater quality of life.
We appreciate you, today and every day! 💙 #TeamVertos
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary at knowyourbackstory.com.
Deer TR, Grider JS, Pope JE, et al. Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2022;15:1325-1354. Published 2022 May 5. doi:10.2147/JPR.S355285.
